(Q37185366)

18 August 2017

Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial (English)

1 reference

attention deficit hyperactivity disorder

18 August 2017

0 references

1 reference

1 reference

1 reference

adult attention deficit hyperactivity disorder

1 reference

6

Adam Bisaga

0 references

Frances R Levin

1

object named as

Frances R Levin

1 reference

18 August 2017

Grace Hennessy

10

0 references

Edward V. Nunes Jr.

7

object named as

Edward Nunes

1 reference

18 August 2017

8

Efrat Aharonovich

1 reference

18 August 2017

9

Wilfrid Raby

1 reference

18 August 2017

John J Mariani

2

1 reference

18 August 2017

Alex Secora

3

1 reference

18 August 2017

Daniel Brooks

4

1 reference

18 August 2017

Wendy Y Cheng

5

1 reference

18 August 2017

1 January 2009

1 reference

Journal of Dual Diagnosis

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

1

1 reference

18 August 2017

41-56

1 reference

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Treatment strategies for co-occurring ADHD and substance use disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

The neural basis of addiction: a pathology of motivation and choice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Dual diagnosis and successful participation of adolescents in substance abuse treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Pharmacotherapy of Adult Attention Deficit/Hyperactivity Disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Use of quantitative urinalysis in monitoring cocaine use.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

A randomized placebo-controlled trial of gabapentin for cocaine dependence

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Double-blind clinical trial of sertraline treatment for alcohol dependence

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Psychotherapy and pharmacotherapy for ambulatory cocaine abusers.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679511

Attention-Deficit/Hyperactivity Disorder and Substance Use: Symptom Pattern and Drug Choice

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F15504260802628767

The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19430599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19430599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19430599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/15504260802628767

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19430599

1 reference